Atkinson, W, Wolfe, S, Hamborsky, J (eds). Epidemiology and Prevention of Vaccine-preventable Diseases. Washington DC: Centers for Disease Control and Prevention, 2012.
Wilson, W, Sande, M (eds). Current Diagnosis and Treatment in Infectious Diseases. New York: McGraw-Hill, 2001.
Plotkin, SA, Orenstein, W, Offit, PA. Vaccines. Philadelphia: Elsevier, 2012.
Tebbens, RJD, et al.
Expert review on poliovirus immunity and transmission. Risk Analysis
2013; 33: 544–605.
Aylward, B, et al.
When is a disease eradicable? 100 years of lessons learned. American Journal of Public Health
2000; 90: 1515–1520.
Hagan, JE, et al.
Progress toward polio eradication – worldwide, 2014–2015. Morbidity and Mortality Weekly Report
2015; 64: 527–531.
Bahl, S, et al.
Polio-free certification and lessons learned–South-East Asia Region, March 2014. Morbidity and Mortality Weekly Report
2014; 63: 941–946.
WHO. Polio eradication and endgame strategic plan 2013–2018. World Health Organization, 2013.
Eichner, M, Brockmann, SO. Polio emergence in Syria and Israel endangers Europe. Lancet
2013; 382: 1777.
Eichner, M, Dietz, K. Eradication of poliomyelitis: when can one be sure that polio virus transmission has been terminated?
American Journal of Epidemiology
1996; 143: 816–822.
Orenstein, WA, et al.
Field evaluation of vaccine efficacy. Bulletin of the World Health Organization
1985; 63: 1055–1068.
Nathanson, N, Kew, OM. From emergence to eradication: the epidemiology of poliomyelitis deconstructed. American Journal of Epidemiology
2010; 172: 1213–1229.
Advisory Committee on Immunization Practices (ACIP). Poliomyelitis prevention in the United States: introduction of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP). Morbidity and Mortality Weekly Report. Recommendations and Reports
1997; 46: 1–25.
Burton, A, et al.
WHO and UNICEF estimates of national infant immunization coverage: methods and processes. Bulletin of the World Health Organization
2009; 87: 535–541.
Hird, TR, Grassly, NC. Systematic review of mucosal immunity induced by oral and inactivated poliovirus vaccines against virus shedding following oral poliovirus challenge. PLoS Pathogens
2012; 8: e1002599.
Okayasu, H, et al.
Mucosal immunity and poliovirus vaccines: impact on wild poliovirus infection and transmission. Vaccine
2011; 29: 8205–8214.
Saltelli, A, et al.
Global Sensitivity Analysis: the Primer. Chichester: Wiley, 2008.
Silverman, BW. Density Estimation for Statistics and Data Analysis. Boca Raton, FL: CRC Press, 1986.
Wolfram Research, Inc. Mathematica, version 9.0. Champaign, IL, 2012.
Gary, HE, Sanders, R, Pallansch, MA. A theoretical framework for evaluating the sensitivity of surveillance for detecting wild poliovirus: II. Factors affecting detection sensitivity in a population with circulating wild poliovirus. Journal of Infectious Diseases
1997; 175: S141–145.
Watkins, RE, et al.
An evaluation of the sensitivity of acute flaccid paralysis surveillance for poliovirus infection in Australia. BMC Infectious Diseases
2009; 9: 162.
Mode, CJ, Candace, K. Stochastic Processes in Epidemiology: HIV/AIDS, Other Infectious Diseases, and Computers. Singapore: World Scientific Publishing, 2010.